Cameron C. Trenor Iii.
Chief Medical Officer, AN2 Therapeutics, Inc.
Companies
- AN2 Therapeutics, Inc.Chief Medical Officer Aug 27, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- AN2 Therapeutics, Inc. ANTX116,667 shares2$381.5K at $3.27Sep 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 15, 2026Granted 116,667 shares of AN2 Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2